Clinical trial
Stem Cell Transplant w/Laronidase for Hurler
NCT00176891 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00176891 |
|---|---|
| Title | Stem Cell Transplant w/Laronidase for Hurler |
| Official title | Phase II Study of Combined Laronidase (AldurazymeTM) Enzyme Replacement Therapy (ERT) With Hematopoietic Stem Cell Transplantation (HSCT) for Hurler Syndrome (MPS IH) |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mucopolysaccharidosis I, Hurler Syndrome |
| Intervention type | Drug, Procedure |
| Interventions | Stem Cell Transplant, Laronidase ERT |
| Enrollment | 25 |
| Start date | Mar 1, 2004 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 11, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: